[{"Assets_0_Q3_USD":120052000.0,"CommonStockSharesOutstanding_0_Q3_shares":74364165.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-35142000.0,"NetIncomeLoss_1_Q3_USD":-15567000.0,"NetIncomeLoss_3_Q3_USD":-39052000.0,"StockholdersEquity_0_Q3_USD":107066000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]